<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <title>Scientific Review</title>
        <link rel = "stylesheet" href = "main.css">
        <link rel = "stylesheet" href = "references.css">
    </head>
    <body>
    </p>
    <center>
        <h1>References</h1>
    </center>
        <ul>
            <li>Burger, A., & Seth, A. (2004, October 1). The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. ScienceDirect. https://www.sciencedirect.com/science/article/abs/pii/S0959804904005660</li>
            <li>Cancer. (2021, March 3). World Health Organization. https://www.who.int/en/news-room/fact-sheets/detail/cancer</li>
            <li>Coussens, N., Braisted, J., Peryea, T., Sittampalam, G., Simeonov, A., & Hall, M. (2017, October 1). Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administrationâ€“Approved Drugs. Pharmacological Reviews. https://pharmrev.aspetjournals.org/content/69/4/479</li>
            <li>Differences between Biologics and Small Molecules. (2020, August 14). UCL Therapeutic Innovation Networks. https://www.ucl.ac.uk/therapeutic-innovation-networks/differences-between-biologics-and-small-molecules</li>
            <li>Han-Chung, W., Chang, D., & Chia-Ting, H. (2006, January). Targeted Therapy for Cancer. Research Gate. https://www.researchgate.net/publication/26576352_Targeted_Therapy_for_Cancer</li>
            <li>Khera, N., & Rajput, S. (2017, May). Therapeutic Potential of Small Molecule Inhibitors. PubMed. https://pubmed.ncbi.nlm.nih.gov/27813176/</li>
            <li>Lavanya, V., Adil, M., Ahmed, N., Rishi, A., & Jamal, S. (2014, November 9). Small molecule inhibitors as emerging cancer therapeutics. OAT Open Access Text. https://www.oatext.com/small-molecule-inhibitors-as-emerging-cancer-therapeutics.php#ICST_jumpmenu7</li>
            <li>Nunes, A., & Annunziata, C. (2017, December 1). Proteasome Inhibitors: Structure and Function. PubMed Central (PMC). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020165/</li>
            <li>Patel, T., Adhikari, N., Amin, A., Biswas, S., Jha, T., & Ghosh, B. (2021, March 29). Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery. New Journal of Chemistry (RSC Publishing). https://pubs.rsc.org/en/content/articlelanding/2021/nj/d0nj04134c#!divAbstract</li>
            <li>Pharmaceutical Drug Development (Small Molecules / Large Molecules). (2021, June 21). Contract Laboratory. http://blog.contractlaboratory.com/pharmaceutical-drug-development-small-molecules-large-molecules/#:%7E:text=Large%20molecules%2C%20or%20biologics%2C%20are,identical%20versions%20of%20human%20proteins.</li>
            <li>Soti, C., & Csermely, P. (n.d.). Molecular chaperones in the etiology and therapy of cancer. NIH National Library of Medicine. Retrieved August 2, 2021, from https://pubmed.ncbi.nlm.nih.gov/9887365/</li>
            <li>Wilkes, G. (2017, September 29). Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents. PubMed Central (PMC). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863423/</li>
            <li>Wu, P., Nielsen, T., & Clausen, M. (2015, July 1). FDA-approved small-molecule kinase inhibitors. ScienceDirect. https://www.sciencedirect.com/science/article/abs/pii/S0165614715000772#:%7E:text=Seven%20approved%20small%2Dmolecule%20inhibitors,%C2%AE%2C%20Eisai%20Inc.</li>
            <li>Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., & Yang, S. (2021, May 31). Small molecules in targeted cancer therapy:. . . Signal Transduction and Targeted Therapy. https://www.nature.com/articles/s41392-021-00572-w?error=cookies_not_supported&code=e7d68080-dc92-42dd-b0e4-e143375d4c44#Sec26</li>
        </ul>
    </p>
    </body>
</html>

